BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6344762)

  • 1. Falciparum malaria: the urgent need for safe and effective drugs.
    Rieckmann KH
    Annu Rev Med; 1983; 34():321-35. PubMed ID: 6344762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

  • 4. Malaria chemoprophylaxis--which drug?
    Biddulph J
    P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.
    Huang OL; Ouyang WC; Zhou JX; Wu Z; Zhang KY; Huang JK; Cai XZ; Pang XJ; Fu SG; Wang XF
    Bull World Health Organ; 1988; 66(3):353-8. PubMed ID: 3048759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malaria chemoprophylaxis. Resistance problems].
    Danis M; Gentilini M
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():971-5. PubMed ID: 3914247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
    Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
    Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271
    [No Abstract]   [Full Text] [Related]  

  • 9. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon ; Tan Puay Eng
    Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique].
    Dinis DV; Schapira A
    Bull Soc Pathol Exot; 1990; 83(4):521-7; discussion 528. PubMed ID: 2286005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
    Pe Than Myint ; Tin Shwe
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):19-22. PubMed ID: 3526578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
    Al-Yaman F; Genton B; Mokela D; Alpers MP
    P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730
    [No Abstract]   [Full Text] [Related]  

  • 19. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 May; 38(20):363-4. PubMed ID: 2497333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasmodium falciparum malaria resistant to polychemotherapy. Usefulness of pathogen culture (author's transl)].
    Dournon E; Le Bras J; Charmot G; Frottier J; Bastin R
    Nouv Presse Med; 1981 Oct; 10(39):3233-6. PubMed ID: 7029457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.